Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Post by stockprospon Jan 14, 2015 4:16pm

142 Views

Post# 23319957

don't see any reason to complain

These prices are great - add more if you can. Look how quick we shot to .78 - this will fly in a hurry. We all know where this is going and it will inevitably be over $1 or $2 when trials are underway. And if successful, well the sky is the limit. I for one am in this for the cancer eradication and view the TLC series as a means to an end along with being a risk mitigant.

Patience folks and GLTA.

Bullboard Posts

A potential breakthrough in spinal cord and optic nerve injury treatment